Incyte Corporation
BICYCLIC DIONE COMPOUNDS AS INHIBITORS OF KRAS

Abstract:

Disclosed are compounds of Formula I, methods of using the compounds for inhibiting KRAS activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with KRAS activity such as cancer.